Company Analysis China Traditional Chinese Medicine Holdings Co. Limited
1. Summary
Disadvantages
- Price (0.336 $) is higher than fair price (0.1599 $)
- Dividends (0%) are below the sector average (2.17%).
- The stock's return over the last year (-29.6%) is lower than the sector average (3.16%).
- Current debt level 103.07% has increased over 5 years from 17.67%.
- The company's current efficiency (ROE=1.05%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
China Traditional Chinese Medicine Holdings Co. Limited | Healthcare | Index | |
---|---|---|---|
7 days | 0% | -0.9% | 0.9% |
90 days | 0% | -2.8% | 8.8% |
1 year | -29.6% | 3.2% | 12% |
CHIZF vs Sector: China Traditional Chinese Medicine Holdings Co. Limited has significantly underperformed the "Healthcare" sector by -32.77% over the past year.
CHIZF vs Market: China Traditional Chinese Medicine Holdings Co. Limited has significantly underperformed the market by -41.64% over the past year.
Stable price: CHIZF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CHIZF with weekly volatility of -0.5693% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (0.336 $) is higher than the fair price (0.1599 $).
Price is higher than fair: The current price (0.336 $) is 52.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (22.45) is lower than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (22.45) is lower than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.7478) is lower than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (0.7478) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.2) is lower than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (1.2) is lower than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.82) is lower than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (8.82) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -18.74% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-18.74%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (1.05%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (1.05%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (0.5714%) is lower than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (0.5714%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (41.14%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription